Carna Biosciences, Inc.
4572.T
Price:
$241
Market Cap:
$4.60B
Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also offers profiling, NanoBRET TE intracellular kinase cell-based assay, protein detection and interaction, live-cell kinase assay, ClariCELL kinase cell-based assay, crystallization, weak affinity chromatography, and tyrosine kinase cell-based assay services, as well as custom production of ultra-pure proteins for crystallography. It also focuses on dev...[Read more]
Industry
Biotechnology
IPO Date
2008-03-25
Stock Exchange
JPX
Ticker
4572.T
PE Ratio
[-2.12]
ROE
[-101.01%]
Current Ratio
[8.63]
Dividend Yield
[0%]
Enterprise Value
[3.56B]
Dividend History
The ROE as of December 2025 (TTM) for Carna Biosciences, Inc. (4572.T) is -101.01%
According to Carna Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -101.01%. This represents a change of 274.04% compared to the average of -27.01% of the last 4 quarters.
Carna Biosciences, Inc. (4572.T) Historical ROE (quarterly & annually)
How has 4572.T ROE performed in the past?
The mean historical ROE of Carna Biosciences, Inc. over the last ten years is -35.69%. The current -101.01% ROE has changed 183.00% with respect to the historical average. Over the past ten years (40 quarters), 4572.T's ROE was at its highest in in the June 2019 quarter at 51.17%. The ROE was at its lowest in in the September 2018 quarter at -47.89%.
Average
-35.69%
Median
-29.39%
Minimum
-136.41%
Maximum
24.40%
Carna Biosciences, Inc. (4572.T) ROE by Quarter and Year
Discovering the peaks and valleys of Carna Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 220.98%
Maximum Annual ROE = 24.40%
Minimum Annual Increase = -235.17%
Minimum Annual ROE = -136.41%
| Year | ROE | Change |
|---|---|---|
| 2024 | -88.01% | 196.01% |
| 2023 | -29.73% | -19.76% |
| 2022 | -37.06% | 199.21% |
| 2021 | -12.38% | -57.37% |
| 2020 | -29.05% | -235.17% |
| 2019 | 21.49% | -115.76% |
| 2018 | -136.41% | 154.94% |
| 2017 | -53.51% | 220.98% |
| 2016 | -16.67% | -168.32% |
| 2015 | 24.40% | -123.92% |
Carna Biosciences, Inc. (4572.T) Average ROE
How has 4572.T ROE performed in the past?
The current ROE of Carna Biosciences, Inc. (4572.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-51.60%
5-year avg
-39.25%
10-year avg
-35.69%
Carna Biosciences, Inc. (4572.T) ROE vs. Peers
How is 4572.T’s ROE compared to its peers?
Carna Biosciences, Inc.’s ROE is greater than Ribomic Inc. (-32.41%), greater than FunPep Company Limited (-55.89%), greater than Delta-Fly Pharma, Inc. (-328.10%), greater than Kubota Pharmaceutical Holdings Co., Ltd. (-82.75%), less than Immuno-Biological Laboratories Co., Ltd. (17.76%), greater than Trans Genic Inc. (-18.55%), greater than D. Western Therapeutics Institute, Inc. (-119.32%), greater than Kringle Pharma, Inc. (-55.80%), less than Human Metabolome Technologies, Inc. (13.28%), greater than Soiken Holdings Inc. (-3.50%),
| Company | ROE | Market cap |
|---|---|---|
| -32.41% | $3.64B | |
| -55.89% | $3.49B | |
| -328.10% | $5.91B | |
| -82.75% | $3.00B | |
| 17.76% | $12.99B | |
| -18.55% | $4.71B | |
| -119.32% | $4.56B | |
| -55.80% | $2.68B | |
| 13.28% | $3.72B | |
| -3.50% | $6.64B |
Build a custom stock screener for Carna Biosciences, Inc. (4572.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carna Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Carna Biosciences, Inc. (4572.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Carna Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Carna Biosciences, Inc.'s ROE?
How is the ROE calculated for Carna Biosciences, Inc. (4572.T)?
What is the highest ROE for Carna Biosciences, Inc. (4572.T)?
What is the 3-year average ROE for Carna Biosciences, Inc. (4572.T)?
What is the 5-year average ROE for Carna Biosciences, Inc. (4572.T)?
How does the current ROE for Carna Biosciences, Inc. (4572.T) compare to its historical average?